Patent ductus arteriosus: are current neonatal treatment options better or worse than no treatment at all?
about
Oral medications regarding their safety and efficacy in the management of patent ductus arteriosusTetralogy of Fallot Surgical Repair: Shunt Configurations, Ductus Arteriosus and the Circle of Willis.Patent ductus arteriosus ligation and adverse outcomes: causality or bias?Activation of the EGFR/p38/JNK pathway by mitochondrial-derived hydrogen peroxide contributes to oxygen-induced contraction of ductus arteriosusEfficacy of paracetamol on patent ductus arteriosus closure may be dose dependent: evidence from human and murine studies.Current Status of Therapeutic Strategies for Patent Ductus Arteriosus in Very-Low-Birth-Weight Infants in Korea.The role of patent ductus arteriosus and its treatments in the development of bronchopulmonary dysplasiaClinical and echocardiographic characteristics associated with the evolution of the ductus arteriosus in the neonate with birth weight lower than 1,500g.Effectiveness and safety of treatments used for the management of patent ductus arteriosus (PDA) in preterm infants: a protocol for a systematic review and network meta-analysis.Serial echocardiography in very preterm infants: a pilot randomized trialPatent ductus arteriosus in preterm infants: do we have the right answers?Comparison of the Mortality and In-Hospital Outcomes of Preterm Infants Treated with Ibuprofen for Patent Ductus Arteriosus with or without Clinical Symptoms Attributable to the Patent Ductus Arteriosus at the Time of Ibuprofen Treatment.Role of dynamin-related protein 1 (Drp1)-mediated mitochondrial fission in oxygen sensing and constriction of the ductus arteriosus.Paracetamol to induce ductus arteriosus closure: is it valid?Management of patent ductus arteriosus in preterm infants--where do we stand?Use of ultrasound in the haemodynamic assessment of the sick neonate.Managing the patent ductus arteriosus: current treatment options.Predictors of bronchopulmonary dysplasia or death in premature infants with a patent ductus arteriosusIbuprofen Versus Indomethacin for Medical Closure of the Patent Arterial Duct: A Pooled Analysis by Route of AdministrationThe impact of a dedicated patent ductus arteriosus ligation team on neonatal health-care outcomes.Outcomes following indomethacin prophylaxis in extremely preterm infants in an all-referral NICU.Reflections of the changes in patent ductus arteriosus management during the last 10 years.Patent Ductus Arteriosus Treatment in Very Preterm Infants: A European Population-Based Cohort Study (EPICE) on Variation and Outcomes.Comparative Effectiveness of Nonsteroidal Anti-inflammatory Drug Treatment vs No Treatment for Patent Ductus Arteriosus in Preterm Infants.Surgical ligation of patent ductus arteriosus in premature infants: trends and practice variation.Paracetamol in Patent Ductus Arteriosus Treatment: Efficacious and Safe?Prophylactic Indomethacin Revisited.Medical closure of patent ductus arteriosus does not reduce mortality and development of bronchopulmonary dysplasia in preterm infants.Prevalence and management of patent ductus arteriosus in a pediatric medicaid cohort.Transcatheter closure of hemodynamic significant patent ductus arteriosus in 32 premature infants by amplatzer ductal occluder additional size-ADOIIAS.Trends and variation in management and outcomes of very low-birth-weight infants with patent ductus arteriosus.Early signs that predict later haemodynamically significant patent ductus arteriosus.Outcomes of Left Ventricular Function According to Treatment Response for a Patent Ductus Arteriosus in Preterm Infants.Development of a Diagnostic Clinical Score for Hemodynamically Significant Patent Ductus Arteriosus.Decreased serum osmolality promotes ductus arteriosus constriction.Evaluation of left ventricular function by tissue Doppler and speckle-derived strain rate echocardiography after percutaneous ductus closure.Using benchmarking to identify inter-centre differences in persistent ductus arteriosus treatment: can we improve outcome?Perinatal factors in patent ductus arteriosus in very low-birthweight infants.Association of Placebo, Indomethacin, Ibuprofen, and Acetaminophen With Closure of Hemodynamically Significant Patent Ductus Arteriosus in Preterm Infants: A Systematic Review and Meta-analysisEarly treatment versus expectative management of patent ductus arteriosus in preterm infants: a multicentre, randomised, non-inferiority trial in Europe (BeNeDuctus trial)
P2860
Q26766965-2D74BB9A-09BC-4D74-A69D-76EA308CBE3DQ33734095-52EDE2A9-BD94-4A04-B372-500B71FFE5E5Q33871314-4DBBDB81-6363-4F22-B780-2D2A9D5E0B5AQ34051516-3BC00E40-58D2-4938-886C-1F6C9DCE70DAQ35064612-C25B0B37-5566-4C5D-8B05-6D7374F1A06BQ36269441-8155A315-0761-4E0A-BAE9-9F5A4C206B2BQ36768333-55FFBCE4-35DF-4418-BC99-0FEB7896BA4EQ36931405-F62EE71A-0C97-41D3-BC6B-940D1C69F8BFQ37133725-3E0CD56B-F04C-4125-A199-87F2451955D7Q37401617-BEEE5C1D-320E-43C5-BF8B-B36773113FB1Q37451050-CF03C275-FFFE-4895-81BA-B93C58EFCD40Q37482391-D6BA0A01-EA6C-40DF-8314-88011DA6A905Q37642322-BCFD4005-E207-4920-A2E4-33F72BAECD9BQ38100781-0B0E9B9D-6EC6-458D-A74A-697A916531F9Q38152796-571D2305-ABAC-40B3-B8D3-7172EDF78AC1Q38204877-BB405FA5-36BC-4720-B093-F821D0ACBD49Q38218037-FD0CF686-3DE4-4BE5-AB68-914DE3085AF4Q38380099-DCA66B16-235A-49CF-8D34-88DC708919C9Q38548285-D8AEF799-BE8B-4F56-9458-11B3BA10E4BDQ38696249-7EF7659A-2786-4662-8A76-3EC2B112121BQ38724573-73218180-C17A-462F-AEF3-AED5E78E4DFAQ38818767-84FE7CAD-69E4-4370-B3AE-545EE01CB8C9Q38997232-FBC6DF0B-808C-40CE-9A83-FAD4B9EC283AQ40398107-DDA8C8A1-BB57-4B7A-8F86-6980849617E8Q40513668-26417C88-DAF2-4529-9F96-CE45DCC49DE3Q41371050-BDCBD92B-E48C-4626-A884-77F2C6853CC5Q42335416-B3FBE5D9-63EA-405F-BE22-4B8C1F5BC99EQ42932652-1A3B8548-86D3-48F9-991D-D66737815E42Q44606747-E836EA50-AF35-414F-AD89-37A6B725DA01Q47215814-87D3AAAC-5407-4F7A-9072-F4336D5ABBC5Q47282381-0D489DC8-5769-4DFB-9339-ACD3076DE2D0Q47830851-847DDCAC-8667-42A1-877C-DE01949C2CCCQ49169521-1B6A21E8-7D25-42D4-93C7-E9D30A99983CQ50128690-97FFFDC2-E357-4617-9CC3-74CFCDBEA98AQ50636634-84F43611-23ED-4B4D-B3F6-D2FD75D24032Q51121929-83B2A516-BDB4-4BE1-93C8-C5BBEF0B0AB1Q52684141-5F241A0D-0DA9-4154-BD0D-FDCBDE0E7ABFQ53094723-091B2DAB-ED4F-4F01-96F1-573B00E98634Q56339020-A700C1C5-BF11-442C-BED2-D42133249B61Q58800590-D71DBE4B-96B6-4738-967F-03AB14B1DF46
P2860
Patent ductus arteriosus: are current neonatal treatment options better or worse than no treatment at all?
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Patent ductus arteriosus: are ...... orse than no treatment at all?
@ast
Patent ductus arteriosus: are ...... orse than no treatment at all?
@en
type
label
Patent ductus arteriosus: are ...... orse than no treatment at all?
@ast
Patent ductus arteriosus: are ...... orse than no treatment at all?
@en
prefLabel
Patent ductus arteriosus: are ...... orse than no treatment at all?
@ast
Patent ductus arteriosus: are ...... orse than no treatment at all?
@en
P2093
P2860
P1476
Patent ductus arteriosus: are ...... orse than no treatment at all?
@en
P2093
Gail M Murphy
James Couto
Ronald I Clyman
P2860
P304
P356
10.1053/J.SEMPERI.2011.09.022
P577
2012-04-01T00:00:00Z